Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if there is a difference in survival between two
different treatment strategies for colorectal peritoneal surface disease. The control arm
administered the currently considered standard treatment which is palliative systemic
chemotherapy. The experimental arm received the combination treatment cytoreductive surgery
and intraperitoneal chemotherapy. The investigators hypothesis is that the combination
treatment will improve the overall survival.